In osteosarcoma, mutations in ATRX lead to upregulation of NF-κB, extracellular matrix remodeling, increased B3 integrin expression, and more aggressive tumor cell phenotypes, including increased growth, migration, invasion, and metastasis [5]. The gene discussed is ATRX; the disease is osteosarcoma.